BROM RECTOR: A few of those are essentially what you may characterize as pharmaceutical companies that happen to be dealing with psychedelics.So I'm thinking that they're, much like with cannabis plus the intended inexperienced wave of expense, that adopted it, will we see, or are we firstly of observing something comparable with Psychedelics, Prof